Citadel Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207K | Sell |
130,948
-376,104
| -74% | -$634K | ﹤0.01% | 11348 |
|
|
2025
Q4 | $847K | Buy |
507,052
+313,084
| +161% | +$542K | ﹤0.01% | 7779 |
|
|
2025
Q3 | $328K | Buy |
193,968
+8,487
| +5% | +$10K | ﹤0.01% | 10154 |
|
|
2025
Q2 | $168K | Buy |
185,481
+137,109
| +283% | +$81.3K | ﹤0.01% | 10849 |
|
|
2025
Q1 | $21.8K | Sell |
48,372
-83,403
| -63% | -$48.9K | ﹤0.01% | 13078 |
|
|
2024
Q4 | $66.2K | Buy |
+131,775
| New | +$96.7K | ﹤0.01% | 12055 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 14881 |
|
|
2024
Q2 | – | Sell |
-221,220
| Closed | -$244K | – | 14980 |
|
|
2024
Q1 | $327K | Sell |
221,220
-366,209
| -62% | -$415K | ﹤0.01% | 9268 |
|
|
2023
Q4 | $640K | Buy |
587,429
+190,496
| +48% | +$209K | ﹤0.01% | 7580 |
|
|
2023
Q3 | $468K | Sell |
396,933
-6,737
| -2% | -$9.17K | ﹤0.01% | 8204 |
|
|
2023
Q2 | $569K | Buy |
403,670
+155,040
| +62% | +$214K | ﹤0.01% | 7662 |
|
|
2023
Q1 | $373K | Buy |
248,630
+120,394
| +94% | +$168K | ﹤0.01% | 8926 |
|
|
2022
Q4 | $150K | Buy |
128,236
+5,440
| +4% | +$6.86K | ﹤0.01% | 10609 |
|
|
2022
Q3 | $139K | Buy |
122,796
+88,254
| +255% | +$130K | ﹤0.01% | 10793 |
|
|
2022
Q2 | $55K | Sell |
34,542
-21,461
| -38% | -$28.3K | ﹤0.01% | 11868 |
|
|
2022
Q1 | $86K | Sell |
56,003
-184,991
| -77% | -$287K | ﹤0.01% | 12418 |
|
|
2021
Q4 | $590K | Buy |
240,994
+169,138
| +235% | +$396K | ﹤0.01% | 9278 |
|
|
2021
Q3 | $181K | Sell |
71,856
-2,448
| -3% | -$6.28K | ﹤0.01% | 12121 |
|
|
2021
Q2 | $212K | Sell |
74,304
-155,914
| -68% | -$403K | ﹤0.01% | 12033 |
|
|
2021
Q1 | $541K | Buy |
230,218
+216,322
| +1,557% | +$519K | ﹤0.01% | 9505 |
|
|
2020
Q4 | $25K | Buy |
+13,896
| New | +$19.4K | ﹤0.01% | 10743 |
|
|
2020
Q3 | – | Sell |
-114,230
| Closed | -$100K | – | 10518 |
|
|
2020
Q2 | $100K | Buy |
114,230
+51,293
| +81% | +$45.1K | ﹤0.01% | 8991 |
|
|
2020
Q1 | $52K | Sell |
62,937
-32,043
| -34% | -$31.9K | ﹤0.01% | 9014 |
|
|
2019
Q4 | $85K | Buy |
94,980
+55,589
| +141% | +$46.3K | ﹤0.01% | 8606 |
|
|
2019
Q3 | $39K | Sell |
39,391
-74,726
| -65% | -$77.4K | ﹤0.01% | 8779 |
|
|
2019
Q2 | $126K | Buy |
114,117
+19,970
| +21% | +$23K | ﹤0.01% | 8438 |
|
|
2019
Q1 | $123K | Sell |
94,147
-62,800
| -40% | -$78.1K | ﹤0.01% | 8474 |
|
|
2018
Q4 | $143K | Buy |
156,947
+43,910
| +39% | +$67.3K | ﹤0.01% | 8084 |
|
|
2018
Q3 | $233K | Buy |
113,037
+17,070
| +18% | +$35.9K | ﹤0.01% | 7987 |
|
|
2018
Q2 | $173K | Sell |
95,967
-105,587
| -52% | -$213K | ﹤0.01% | 7996 |
|
|
2018
Q1 | $475K | Buy |
201,554
+31,460
| +18% | +$73.8K | ﹤0.01% | 5958 |
|
|
2017
Q4 | $320K | Buy |
170,094
+95,014
| +127% | +$207K | ﹤0.01% | 6357 |
|
|
2017
Q3 | $187K | Buy |
75,080
+5,738
| +8% | +$14.2K | ﹤0.01% | 6747 |
|
|
2017
Q2 | $192K | Buy |
69,342
+34,522
| +99% | +$96.4K | ﹤0.01% | 6607 |
|
|
2017
Q1 | $105K | Sell |
34,820
-27,420
| -44% | -$77.9K | ﹤0.01% | 6843 |
|
|
2016
Q4 | $197K | Buy |
+62,240
| New | +$191K | ﹤0.01% | 6314 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7449 |
|
|
2015
Q4 | – | Sell |
-4,205
| Closed | -$12.6K | – | 8979 |
|
|
2015
Q3 | $10K | Sell |
4,205
-10,742
| -72% | -$27.8K | ﹤0.01% | 8468 |
|
|
2015
Q2 | $44K | Sell |
14,947
-93,713
| -86% | -$363K | ﹤0.01% | 7738 |
|
|
2015
Q1 | $436K | Buy |
108,660
+100,625
| +1,252% | +$348K | ﹤0.01% | 5117 |
|
|
2014
Q4 | $24K | Sell |
8,035
-39,204
| -83% | -$106K | ﹤0.01% | 7671 |
|
|
2014
Q3 | $120K | Buy |
47,239
+33,336
| +240% | +$80.3K | ﹤0.01% | 6240 |
|
|
2014
Q2 | $34K | Sell |
13,903
-3,244
| -19% | -$7.33K | ﹤0.01% | 7007 |
|
|
2014
Q1 | $46K | Buy |
17,147
+1,319
| +8% | +$3.88K | ﹤0.01% | 6835 |
|
|
2013
Q4 | $46K | Buy |
15,828
+15,109
| +2,101% | +$45.6K | ﹤0.01% | 6094 |
|
|
2013
Q3 | $2K | Buy |
719
+176
| +32% | +$557 | ﹤0.01% | 6650 |
|
|
2013
Q2 | $2K | Buy |
+543
| New | +$1.74K | ﹤0.01% | 6414 |
|
Other funds holding LCTX
BC
VCM
DC
RA
AC
